Cite

HARVARD Citation

    Morihara, D. et al. (n.d.). Adjusting the starting dose of telaprevir according to renal function decreases adverse effects and affects the sustained virological response rate. European journal of gastroenterology & hepatology. 27 (1), p. . [Online]. 
  
Back to record